Immunocore Holdings plc Prepayments And Accrued Income Other Than Contract Assets
Immunocore Holdings plc (IMCR) had Prepayments And Accrued Income Other Than Contract Assets of GBP 10.66 million as of 2023-06-30, per its 6-K filed 2023-08-10.
Discontinued › Notes
ifrs-full:PrepaymentsAndAccruedIncomeOtherThanContractAssets · last filed 2023-08-10
- 2023-06-30: Prepayments And Accrued Income Other Than Contract Assets 10.66M GBP.
- 2022-12-31: Prepayments And Accrued Income Other Than Contract Assets 11.29M GBP.
- 2022-09-30: Prepayments And Accrued Income Other Than Contract Assets 8.95M GBP.
- 2021-12-31: Prepayments And Accrued Income Other Than Contract Assets 7.69M GBP.
| Period end | Prepayments And Accrued Income Other Than Contract Assets |
|---|---|
| 2023-06-30 | 10.66M GBP 6-K · filed 2023-08-10 |
| 2022-12-31 | 11.29M GBP 6-K · filed 2023-08-10 |
| 2022-09-30 | 8.95M GBP 6-K/A · filed 2022-11-18 |
| 2021-12-31 | 7.69M GBP 20-F · filed 2023-03-01 |
| 2020-12-31 | 6.51M GBP 20-F · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |